Animal Health
Equine Veterinary Therapeutics Market

Equine Veterinary Therapeutics Market Size, Share, Growth, and Regional Forecast, 2026 to 2033

Equine Veterinary Therapeutics Market by Drugs (Anti-Inflammatory, Anti-Infective, Parasiticides, Others), by Route of Administration (Oral, Parental, Topical), by Service, by Distribution Channel, and Regional Analysis from 2026 to 2033

ID: PMRREP33965

December 2025

210 Pages

Author : Pravin Rewale

Healthcare

Preview Segmentation

Key Industry Highlights

Increasing human affinity for horses is driving the market growth.
Growing awareness for animal health is fueling the need for efficient equine veterinary therapeutics.
Rising concern for horse diseases highlights the need for meticulous horse care and treatment.
Rising horse ownership for sport, recreation, racing, companionship, and therapeutic riding is increasing demand for veterinary services and medicines.
Anti-inflammatory drugs (including NSAIDs, corticosteroids, and pain-relief formulations) are used most frequently for managing lameness, joint disease, musculoskeletal injuries, post-surgical pain, and chronic orthopedic conditions - all extremely common in sport, racing, and working horses.

Key Insights	Details
Equine Veterinary Therapeutics Market Size (2026E)	US$1.8 Bn
Market Value Forecast (2033F)	US$2.8 Bn
Projected Growth (CAGR 2026 to 2033)	7.5%
Historical Market Growth (CAGR 2020 to 2024)	5.5%

equine-veterinary-therapeutics-market-2026–2033

Get Your CustomizationGet Your Customization

Market Dynamics

Driver - Rising Awareness of Equine Health and Expansion of Equestrian Sports

Growing awareness and focus on animal health, supported by increased R&D investments-where animal-health manufacturers spend about 8.5% of sales on innovation-is propelling market growth. Rising human affinity for horses and routine maintenance care are further improving adoption of veterinary products.

Simultaneously, the fast-expanding equestrian sports industry, including racing, show jumping, and dressage, demands peak horse fitness and effective treatment for injuries and infectious risks. Together, these trends are driving strong demand for preventive and therapeutic equine veterinary services and medicines.

Restraints - Elevated Cost of Veterinary Therapeutics, and Lack of Skilled Equestrians

Equine veterinary treatment, especially advanced treatments and specialized medicines, can incur high costs. These increased costs associated with therapeutics can become a barrier that restricts horse owners from taking precise treatments.

Furthermore, the equine veterinary medicine sector requires specialized skills, knowledge, and experience due to the scope of this domain and the distinctive anatomy and physiology of horses. However, a scarcity of skilled equine veterinarians is causing challenges to ensure the mandated availability and easy accessibility of experts who can offer efficient care and therapeutics.

Opportunity - Advanced Technologies and Emphasis on Regenerative Medicine

Expanding regional areas such as Asia Pacific, and Latin America show notable growth opportunities for the equine veterinary therapeutics market. The increasing interest among people in equestrian sports, extending investments in the equine sector, and advances in healthcare facilities contribute to market expansion in these areas. Advancements in veterinary medicine, such as telemedicine and wearable devices, highlight the novel possibilities for equine healthcare.

The advancements offer a wide range of benefits, including remote consultations, real-time monitoring, early detection of symptoms and health problems, and analysis of health parameters. Further, the introduction of regenerative medicines, such as stem cell therapy and platelet-rich plasma therapy, emerges as a novel treatment option in equine healthcare. These therapies are gaining momentum by showing promising treatment outcomes for musculoskeletal injuries.

Category-wise Analysis

By drugs, the Anti-Inflammatory Segment is leading in the Market

Based on drugs, the equine veterinary therapeutics market is categorized into several types, among which the non-steroidal anti-inflammatory drugs (NSAIDs) held the largest revenue share in 2024.

NSAIDs such as phenylbutazone and flunixin are routinely employed for their analgesic and anti-inflammatory properties to manage a spectrum of conditions in horses, ranging from abdominal to orthopedic pain. The parasiticides segment is integral to the equine veterinary therapeutics market, playing a crucial role in the treatment and prevention of various equine diseases.

Additionally, in this field, Visco supplements are anticipated to witness the fastest market growth over the forecast period, indicating the evolving landscape of therapeutic interventions in equine veterinary medicine.

By Veterinary Hospital Insights

Veterinary hospitals command the highest share in the equine veterinary therapeutics market because most advanced treatments, surgeries, diagnostics, and emergency care for horses are performed in these specialized facilities. Hospitals maintain immediate access to prescription medicines, biologics, regenerative therapies, and controlled drugs that cannot be purchased independently.

Their in-house pharmacies ensure seamless treatment continuity, while owners prefer hospitals for comprehensive care, expert veterinarians, specialized equipment, and faster recovery outcomes. Since sport, racing, and working horses often require intensive medical attention for injuries and chronic orthopedic issues, hospitals remain the primary point of purchase for high-value therapeutics and ongoing treatment plans.

equine-veterinary-therapeutics-market-outlook-by-product-2026–2033

Request Free sampleRequest Free sample

Region-wise Insights

North America Equine Veterinary Therapeutics Market Trends

North America leads the equine veterinary therapeutics market owing to its large and economically valuable horse population and a strong culture of equestrian sports. According to FAO, the region housed about 10.96 million horses in 2021, with 10.56 million in the U.S. alone.

The U.S. also has nearly 300 racetracks hosting around 33,567 horse races annually, significantly increasing cases of injuries and performance-related health issues. According to the National Institute of Health, injury rates are highest in jump races at 68.9 per 1,000 starts compared to 8.8 in flat races, highlighting the need for timely and advanced treatment.

High horse import volumes, widespread farms, and strong owner willingness to invest in animal health further reinforce North America’s dominant market position.

Asia Pacific Equine Veterinary Therapeutics Market Trends

Asia Pacific equine veterinary therapeutics market is rapidly emerging due to rising horse ownership, expanding equestrian sports, and growing awareness of animal health. Increasing investments in horse racing, polo, and recreational riding are boosting demand for preventive and therapeutic care. Countries such as China, India, and Australia are witnessing growth in equine hospitals, specialized clinics, and mobile veterinary services.

Moreover, government initiatives supporting livestock and equine welfare, coupled with rising disposable incomes among horse owners, are encouraging adoption of vaccines, anti-infectives, and regenerative therapies. The market is expected to gain momentum as infrastructure, veterinary expertise, and awareness continue to improve.

equine-veterinary-therapeutics-market-outlook-by-region-2026–2033

Competitive Landscape

The equine veterinary therapeutics market report provides valuable insight with an emphasis on the dynamic nature of this market. Key players are primarily focusing on product launches and advancements in this domain.

Further, they focus on several major business approaches, such as mergers, partnerships, acquisitions, and joint ventures, to develop their product offerings. It will also help them boost their market shares across different areas. Manufacturers of equine veterinary therapeutics are embracing novel strategies, including investments in R&D activities, the installation of manufacturing and production facilities, and supply chain management, to strengthen their market position.

Key Industry Developments:

In October 2025, PetVivo Animal Health, Inc., a wholly owned subsidiary of PetVivo Holdings, Inc., entered into a Vendor Partner Agreement (“Agreement”) with Veterinary Growth Partners (“VGP”). Veterinary Growth Partners, a management services organization (MSO), supported veterinary practices by providing practice management and marketing tools, consulting, and vendor relationships to help improve efficiency, profitability, and overall operations.

Companies Covered in Equine Veterinary Therapeutics Market

Merck Animal Heath
Affymetrix
Elanco Animal Health
Zoetis (Pfizer Animal Health)
Equine Health UK
PetVivo Holdings, Inc.
Other

Frequently Asked Questions

The global equine veterinary therapeutics market is projected to be valued at US$1.8 Bn in 2026.

Increasing numbers of horses for sports, recreation, racing, and companionship drive demand for preventive and therapeutic care.

The global market is poised to witness a CAGR of 7.5% between 2026 and 2033.

Use of digital diagnostics, wearable sensors, telemedicine, and AI-driven performance monitoring.

Merck Animal Heath, Affymetrix, Elanco Animal Health, Zoetis (Pfizer Animal Health), and others.

Report Attribute	Details
Historical Data/Actuals	2020 - 2024
Forecast Period	2026 - 2033
Market Analysis	Value: US$ Mn
Geographical Coverage	North America Europe East Asia South Asia and Oceania Middle East and Africa Latin America
Segmental Coverage	By Drugs By Route of Administration By Services By Distribution Channel By Region
Competitive Analysis	Merck Animal Heath Affymetrix Elanco Animal Health Zoetis (Pfizer Animal Health) Equine Health UK PetVivo Holdings, Inc. Other
Report Highlights	Market Forecast and Trends Competitive Intelligence & Share Analysis Growth Factors and Challenges Strategic Growth Initiatives Future Opportunities and Revenue Pockets Market Analysis Tools

Top-Down Market Sizing	Bottom-Up Market Sizing
Universe Definition: Total global/regional market identification	Unit Economics: Average transaction values, purchase frequencies, customer lifecycle
Segmentation Filters: Geographic, demographic, and behavioral constraints	Customer Segmentation: Detailed buyer persona development and sizing
Market Share Analysis: Competitive landscape assessment and share allocation	Penetration Analysis: Market penetration rates by segment and geography
Growth Rate Application: Historical trends and forward-looking growth assumptions	Scaling Methodology: Extrapolation techniques with confidence intervals

Interested in this report?

Request customization, ask for expert consulting, access a sample report, or simply express your interest—our team will assist you with the right insights and solutions.

Request Custom VersionRequest Custom Version

Clients

Media Citation

Get In Touch

Loading page data

Please wait a moment

Key Insights

Details

Equine Veterinary Therapeutics Market Size (2026E)

US$1.8 Bn

Market Value Forecast (2033F)

US$2.8 Bn

Projected Growth (CAGR 2026 to 2033)

7.5%

Historical Market Growth (CAGR 2020 to 2024)

5.5%

Report Attribute	Details
Historical Data/Actuals	2020 - 2024
Forecast Period	2026 - 2033
Market Analysis	Value: US$ Mn
Geographical Coverage	North America Europe East Asia South Asia and Oceania Middle East and Africa Latin America
Segmental Coverage	By Drugs By Route of Administration By Services By Distribution Channel By Region
Competitive Analysis	Merck Animal Heath Affymetrix Elanco Animal Health Zoetis (Pfizer Animal Health) Equine Health UK PetVivo Holdings, Inc. Other
Report Highlights	Market Forecast and Trends Competitive Intelligence & Share Analysis Growth Factors and Challenges Strategic Growth Initiatives Future Opportunities and Revenue Pockets Market Analysis Tools

Executive Summary
1. Global Equine Veterinary Therapeutics Market Snapshot, 2026 and 2033
2. Market Opportunity Assessment, 2026 - 2033, US$ Mn
3. Key Market Trends
4. Future Market Projections
5. Premium Market Insights
6. Industry Developments and Key Market Events
7. PMR Analysis and Recommendations
Market Overview
1. Market Scope and Definition
2. Market Dynamics
  1. Drivers
  2. Restraints
  3. Opportunity
  4. Challenges
  5. Key Trends
3. Macro-Economic Factors
  1. Global Sectorial Outlook
  2. Global GDP Growth Outlook
4. COVID-19 Impact Analysis
5. Forecast Factors - Relevance and Impact
Value Added Insights
1. Drug Adoption Analysis
2. Regulatory Landscape
3. Value Chain Analysis
4. Key Deals and Mergers
5. PESTLE Analysis
6. Porter’s Five Force Analysis
Global Equine Veterinary Therapeutics Market Outlook:
1. Key Highlights
  1. Market Size (US$ Mn) and Y-o-Y Growth
  2. Absolute $ Opportunity
2. Market Size (US$ Mn) Analysis and Forecast
  1. Historical Market Size (US$ Mn) Analysis, 2020-2024
  2. Market Size (US$ Mn) Analysis and Forecast, 2026-2033
3. Global Equine Veterinary Therapeutics Market Outlook: Drug
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) Analysis, By Drug, 2020 - 2024
  3. Market Size (US$ Mn) Analysis and Forecast, By Drug, 2026 - 2033
    1. Anti-Inflammatory
    2. Anti-Infective
    3. Parasiticides
    4. Others
  4. Market Attractiveness Analysis: Drug
4. Global Equine Veterinary Therapeutics Market Outlook: Route of Administration
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) Analysis, By Route of Administration, 2020 - 2024
  3. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2026 - 2033
    1. Oral
    2. Parental
    3. Topical
  4. Market Attractiveness Analysis: Route of Administration
5. Global Equine Veterinary Therapeutics Market Outlook: Services
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) Analysis, By Services, 2020 - 2024
  3. Market Size (US$ Mn) Analysis and Forecast, By Services, 2026 - 2033
    1. Diagnostic Tests and Imaging
    2. Physical Health Monitoring
    3. Surgery
    4. Vaccination
    5. Others
  4. Market Attractiveness Analysis: Services
6. Global Equine Veterinary Therapeutics Market Outlook: Distribution Channel
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) Analysis, By Distribution Channel, 2020 - 2024
  3. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026 - 2033
    1. Veterinary Hospital
    2. Veterinary Clinics
    3. Pharmacies and drug stores
    4. E-commerce
    5. Other
  4. Market Attractiveness Analysis: Distribution Channel
Global Equine Veterinary Therapeutics Market Outlook: Region
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Region, 2020 - 2024
3. Market Size (US$ Mn) Analysis and Forecast, By Region, 2026 - 2033
  1. North America
  2. Europe
  3. East Asia
  4. South Asia and Oceania
  5. Latin America
  6. Middle East & Africa
4. Market Attractiveness Analysis: Region
North America Equine Veterinary Therapeutics Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2020 - 2024
  1. By Country
  2. By Drug
  3. By Route of Administration
  4. By Services
  5. By Distribution Channel
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026 - 2033
  1. U.S.
  2. Canada
4. Market Size (US$ Mn) Analysis and Forecast, By Drug, 2026 - 2033
  1. Anti-Inflammatory
  2. Anti-Infective
  3. Parasiticides
  4. Others
5. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2026 - 2033
  1. Oral
  2. Parental
  3. Topical
6. Market Size (US$ Mn) Analysis and Forecast, By Services, 2026 - 2033
  1. Diagnostic Tests and Imaging
  2. Physical Health Monitoring
  3. Surgery
  4. Vaccination
  5. Others
7. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026 - 2033
  1. Diagnostic Tests and Imaging
  2. Physical Health Monitoring
  3. Surgery
  4. Vaccination
  5. Others
8. Market Attractiveness Analysis
Europe Equine Veterinary Therapeutics Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2020 - 2024
  1. By Country
  2. By Drug
  3. By Route of Administration
  4. By Services
  5. By Distribution Channel
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026 - 2033
  1. Germany
  2. France
  3. U.K.
  4. Italy
  5. Spain
  6. Russia
  7. Türkiye
  8. Rest of Europe
4. Market Size (US$ Mn) Analysis and Forecast, By Drug, 2026 - 2033
  1. Anti-Inflammatory
  2. Anti-Infective
  3. Parasiticides
  4. Others
5. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2026 - 2033
  1. Oral
  2. Parental
  3. Topical
6. Market Size (US$ Mn) Analysis and Forecast, By Services, 2026 - 2033
  1. Diagnostic Tests and Imaging
  2. Physical Health Monitoring
  3. Surgery
  4. Vaccination
  5. Others
7. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026 - 2033
  1. Diagnostic Tests and Imaging
  2. Physical Health Monitoring
  3. Surgery
  4. Vaccination
  5. Others
8. Market Attractiveness Analysis
East Asia Equine Veterinary Therapeutics Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2020 - 2024
  1. By Country
  2. By Drug
  3. By Route of Administration
  4. By Services
  5. By Distribution Channel
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026 - 2033
  1. China
  2. Japan
  3. South Korea
4. Market Size (US$ Mn) Analysis and Forecast, By Drug, 2026 - 2033
  1. Anti-Inflammatory
  2. Anti-Infective
  3. Parasiticides
  4. Others
5. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2026 - 2033
  1. Oral
  2. Parental
  3. Topical
6. Market Size (US$ Mn) Analysis and Forecast, By Services, 2026 - 2033
  1. Diagnostic Tests and Imaging
  2. Physical Health Monitoring
  3. Surgery
  4. Vaccination
  5. Others
7. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026 - 2033
  1. Diagnostic Tests and Imaging
  2. Physical Health Monitoring
  3. Surgery
  4. Vaccination
  5. Others
8. Market Attractiveness Analysis
South Asia & Oceania Equine Veterinary Therapeutics Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2020 - 2024
  1. By Country
  2. By Drug
  3. By Route of Administration
  4. By Services
  5. By Distribution Channel
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026 - 2033
  1. India
  2. Southeast Asia
  3. ANZ
  4. Rest of South Asia & Oceania
4. Market Size (US$ Mn) Analysis and Forecast, By Drug, 2026 - 2033
  1. Anti-Inflammatory
  2. Anti-Infective
  3. Parasiticides
  4. Others
5. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2026 - 2033
  1. Oral
  2. Parental
  3. Topical
6. Market Size (US$ Mn) Analysis and Forecast, By Services, 2026 - 2033
  1. Diagnostic Tests and Imaging
  2. Physical Health Monitoring
  3. Surgery
  4. Vaccination
  5. Others
7. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026 - 2033
  1. Diagnostic Tests and Imaging
  2. Physical Health Monitoring
  3. Surgery
  4. Vaccination
  5. Others
8. Market Attractiveness Analysis
Latin America Equine Veterinary Therapeutics Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2020 - 2024
  1. By Country
  2. By Drug
  3. By Route of Administration
  4. By Services
  5. By Distribution Channel
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026 - 2033
  1. Brazil
  2. Mexico
  3. Rest of Latin America
4. Market Size (US$ Mn) Analysis and Forecast, By Drug, 2026 - 2033
  1. Anti-Inflammatory
  2. Anti-Infective
  3. Parasiticides
  4. Others
5. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2026 - 2033
  1. Oral
  2. Parental
  3. Topical
6. Market Size (US$ Mn) Analysis and Forecast, By Services, 2026 - 2033
  1. Diagnostic Tests and Imaging
  2. Physical Health Monitoring
  3. Surgery
  4. Vaccination
  5. Others
7. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026 - 2033
  1. Diagnostic Tests and Imaging
  2. Physical Health Monitoring
  3. Surgery
  4. Vaccination
  5. Others
8. Market Attractiveness Analysis
Middle East & Africa Equine Veterinary Therapeutics Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2020 - 2024
  1. By Country
  2. By Drug
  3. By Route of Administration
  4. By Services
  5. By Distribution Channel
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026 - 2033
  1. GCC Countries
  2. Egypt
  3. South Africa
  4. Northern Africa
  5. Rest of Middle East & Africa
4. Market Size (US$ Mn) Analysis and Forecast, By Drug, 2026 - 2033
  1. Anti-Inflammatory
  2. Anti-Infective
  3. Parasiticides
  4. Others
5. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2026 - 2033
  1. Oral
  2. Parental
  3. Topical
6. Market Size (US$ Mn) Analysis and Forecast, By Services, 2026 - 2033
  1. Diagnostic Tests and Imaging
  2. Physical Health Monitoring
  3. Surgery
  4. Vaccination
  5. Others
7. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026 - 2033
  1. Diagnostic Tests and Imaging
  2. Physical Health Monitoring
  3. Surgery
  4. Vaccination
  5. Others
8. Market Attractiveness Analysis
Competition Landscape
1. Market Share Analysis, 2024
2. Market Structure
  1. Competition Intensity Mapping By Market
  2. Competition Dashboard
3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  1. Merck Animal Health
    1. Overview
    2. Segments and Products
    3. Key Financials
    4. Market Developments
    5. Market Strategy
  2. Affymetrix
  3. Elanco Animal Health
  4. Zoetis (Pfizer Animal Health)
  5. Equine Health UK
  6. PetVivo Holdings, Inc.
  7. Others
Appendix
1. Research Methodology
2. Research Assumptions
3. Acronyms and Abbreviations

Equine Veterinary Therapeutics Market Size, Share, Growth, and Regional Forecast, 2026 to 2033

Equine Veterinary Therapeutics Market by Drugs (Anti-Inflammatory, Anti-Infective, Parasiticides, Others), by Route of Administration (Oral, Parental, Topical), by Service, by Distribution Channel, and Regional Analysis from 2026 to 2033